These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3798420)

  • 1. Activators and inhibitors of coagulation and fibrinolysis in patients with prostatic cancer treated with oestrogen or orchidectomy.
    Henriksson P; Blombäck M; Bratt G; Edhag O; Eriksson A
    Thromb Res; 1986 Dec; 44(6):783-91. PubMed ID: 3798420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oestrogen therapy and orchidectomy on coagulation and prostanoid synthesis in patients with prostatic cancer.
    Henriksson P; Blombäck M; Bratt G; Edhag O; Eriksson A; Vesterqvist O
    Med Oncol Tumor Pharmacother; 1989; 6(3):219-25. PubMed ID: 2515399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in blood coagulation and fibrinolysis in patients on different treatment regimens for prostatic cancer. Predictors for cardiovascular complications?
    Blombäck M; Hedlund PO; Säwe U
    Thromb Res; 1988 Jan; 49(1):111-21. PubMed ID: 3126558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural oestrogen in the female climacteric--influence on blood coagulation and fibrinolysis.
    Lagrelius A; Lunell NO; Blombäck M
    Thromb Haemost; 1979 Feb; 40(3):532-41. PubMed ID: 154749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of parenteral estrogen versus orchiectomy on blood coagulation and fibrinolysis in prostatic cancer patients.
    Aro J; Haapiainen R; Rasi V; Rannikko S; Alfthan O
    Eur Urol; 1990; 17(2):161-5. PubMed ID: 2178941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of parenteral oestrogen on the coagulation system in patients with prostatic carcinoma.
    Henriksson P; Blombäck M; Eriksson A; Stege R; Carlström K
    Br J Urol; 1990 Mar; 65(3):282-5. PubMed ID: 2110842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulative and fibrinolytic studies on postmenopausal women treated with a new non-steroidal oestrogen.
    Kullander S; Svanberg L; Astedt B
    Acta Obstet Gynecol Scand; 1977; 56(4):371-4. PubMed ID: 74933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogenic treatment of prostatic cancer lowers the fibrinolytic activity in vein walls.
    Carlsson S; Astedt B
    Scand J Urol Nephrol; 1974; 8(3):169-72. PubMed ID: 4139751
    [No Abstract]   [Full Text] [Related]  

  • 10. Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.
    Henriksson P; Edhag O
    Br Med J (Clin Res Ed); 1986 Aug; 293(6544):413-5. PubMed ID: 3091138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deleterious effects of low-dose oestrogen therapy on coronary status in patients with prostatic cancer.
    Henriksson P; Linde B; Edhag O
    Eur Heart J; 1987 Jul; 8(7):779-84. PubMed ID: 3653128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism.
    Ockrim JL; Lalani el-N; Kakkar AK; Abel PD
    J Urol; 2005 Aug; 174(2):527-33; discussion 532-3. PubMed ID: 16006886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on coagulation and fibrinolysis in blood from puerperal women with and without oestrogen treatment.
    Gjonnaess H; Fagerhol MK; Stormorken H
    Br J Obstet Gynaecol; 1975 Feb; 82(2):151-7. PubMed ID: 123756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of an injectable progestogen contraceptive on blood coagulation and fibrinolysis.
    Whigham KA; Howie PW; Mack A; Prentice CR
    Br J Obstet Gynaecol; 1979 Oct; 86(10):806-9. PubMed ID: 508662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation and fibrinolysis in post-menopausal women treated with Org OD 14.
    Cortes-Prieto J
    Maturitas; 1987; Suppl 1():67-72. PubMed ID: 3306292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.